Prosecution Insights
Last updated: April 19, 2026

Athos Therapeutics, Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18551281 SMALL MOLECULES FOR THE TREATMENT OF KINASE-RELATED DISEASES KIFLE, BRUCK 1624 Non-Final OA Sep 19, 2023
18262712 TRIAZINE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Jul 24, 2023
18262676 PHARMACEUTICAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MCKOY, QUINCY ANDRE 1626 Final Rejection Jul 24, 2023
18040422 EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS CHEU, CHANGHWA J 1678 Non-Final OA Feb 02, 2023

Managing Athos Therapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month